BBIO Dividend: BridgeBio Pharma Inc Yield Insights

BBIO Financial

BridgeBio Pharma Inc

$74.59

0.59%

$0.44

At close: Dec 04, 16:00:00 GMT-5

$74.59

Post-market: Dec 04, 17:53:51 GMT-5

360

Report

Final Score

Income

Balance sheet

Cash flow

Annual

Quarterly

BBIO Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	353	221	9	77	69	8
Revenue Growth (YoY)	63%	2,356%	-88%	12%	763%	-80%
Cost of Revenue	14	3	2	3	3	0
Gross Profit	338	218	6	74	66	8
Selling, General & Admin	467	288	150	143	192	145
Research & Development	465	506	455	399	451	337
Operating Expenses	933	795	606	542	643	482
Other Non Operating Income (Expenses)	32	4	0	-7	35	1
Pretax Income	-803	-542	-653	-484	-586	-505
Income Tax Expense	1	1	--	--	--	--
Net Income	-797	-535	-643	-481	-562	-448
Net Income Growth	82%	-17%	34%	-14%	25%	72%
Shares Outstanding (Diluted)	191.85	186.07	162.79	147.47	144.36	118
Shares Change (YoY)	2%	14%	10%	2%	22%	12%
EPS (Diluted)	-4.15	-2.87	-3.95	-3.26	-3.9	-3.8
EPS Growth	79%	-27%	21%	-16%	3%	53%
Free Cash Flow	-597	-529	-529	-425	-511	-407
Free Cash Flow Per Share	-3.11	-2.84	-3.24	-2.88	-3.53	-3.44
Gross Margin	95.75%	98.64%	66.66%	96.1%	95.65%	100%
Operating Margin	-168.27%	-261.08%	-6,655.55%	-607.79%	-834.78%	-5,925%
Profit Margin	-225.77%	-242.08%	-7,144.44%	-624.67%	-814.49%	-5,600%
Free Cash Flow Margin	-169.12%	-239.36%	-5,877.77%	-551.94%	-740.57%	-5,087.5%
EBITDA	-589	-571	-593	-462	-571	--
EBITDA Margin	-166.85%	-258.37%	-6,588.88%	-600%	-827.53%	--
D&A For EBITDA	5	6	6	6	5	--
EBIT	-594	-577	-599	-468	-576	-474
EBIT Margin	-168.27%	-261.08%	-6,655.55%	-607.79%	-834.78%	-5,925%
Effective Tax Rate	-0.12%	-0.18%	--	--	--	--